Showing results (621-630 of 2,229) with videos related to
Sort By:
Pageof 223
Cancer Biotherapy & Radiopharmaceuticals|October 18, 2019
Direct Interstitial Treatment of Solid Tumors Using an Injectable Yttrium-90-Polymer CompositeDarrell R Fisher, Janean Fidel, Charles A MaitzCancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Tumor cell growth suppression by tannic acidH Kamei, T Koide, Y Hashimoto, et al.Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Efficient recombination of Lym-1 scFv gene using multiple doubly-restricted DNA fragmentsX B Shi, P H Gumerlock, L Kroger, et al.Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Comparison of melanoma antigens in whole tumor vaccine to those from IIB-MEL-J cellsJ M McGee, M R Patten, K F Malnar, et al.Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Angiogenesis and growth of murine colon carcinoma are dependent on infiltrating leukocytesJ Yoneda, J J Killion, C D Bucana, et al.Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Immunotherapeutic potential of dendritic cells generated in long-term stroma-dependent culturesH C O'Neill, N Jonas, H Wilson, et al.Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
A new chemically modified chimeric TNT-3 monoclonal antibody directed against DNA for the radioimmunotherapy of solid tumorsJ L Hornick, J Sharifi, L A Khawli, et al.Cancer Biotherapy & Radiopharmaceuticals|June 14, 2000
Combined modality radioimmunotherapy with Taxol and 90Y-Lym-1 for Raji lymphoma xenograftsR T O'Donnell, S J DeNardo, L A Miers, et al.Cancer Biotherapy & Radiopharmaceuticals|June 14, 2000
Liposomal muramyl tripeptide (CGP 19835A lipid) therapy for resectable melanoma in patients who were at high risk for relapse: an updateM A Gianan, E S KleinermanCancer Biotherapy & Radiopharmaceuticals|June 14, 2000
Impaired proliferation and DNA synthesis of a human tumor cell line (HeLa) caused by short treatment with the anti-anemic drug jectofer (ferric-sorbitol-citrate) and the lipid peroxidation product 4-hydroxynonenalM Poljak-Blazi, N Zarkovic, R J SchaurPageof 223